STCube Inc
KOSDAQ:052020
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
STCube Inc
Accounts Receivables
STCube Inc
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
STCube Inc
KOSDAQ:052020
|
Accounts Receivables
₩2.3B
|
CAGR 3-Years
55%
|
CAGR 5-Years
10%
|
CAGR 10-Years
17%
|
|
|
M
|
Makus Inc
KOSDAQ:093520
|
Accounts Receivables
₩22.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-5%
|
|
|
S
|
SAMT Co Ltd
KOSDAQ:031330
|
Accounts Receivables
₩408.9B
|
CAGR 3-Years
14%
|
CAGR 5-Years
26%
|
CAGR 10-Years
15%
|
|
|
D
|
Dmoa Co Ltd
KOSDAQ:016670
|
Accounts Receivables
₩32.6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
6%
|
|
|
M
|
Medifron DBT Co Ltd
KOSDAQ:065650
|
Accounts Receivables
₩17B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
38%
|
CAGR 10-Years
35%
|
|
|
U
|
Unitron Tech Co Ltd
KOSDAQ:142210
|
Accounts Receivables
₩85.5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
22%
|
|
STCube Inc
Glance View
STCube, Inc. engages in the development and distribution of information technology (IT) services. The company is headquartered in Seoul, Seoul. The company went IPO on 2001-07-05. Along with subsidiaries, the Company operates its business through two segments. The Information Technology (IT) segment is engaged in the distribution of closed-circuit television (CCTV) lenses and related components. The Biotechnology (BT) segment is engaged in the development and licensing of immunomodulatory anticancer drug therapeutic candidates.
See Also
What is STCube Inc's Accounts Receivables?
Accounts Receivables
2.3B
KRW
Based on the financial report for Dec 31, 2025, STCube Inc's Accounts Receivables amounts to 2.3B KRW.
What is STCube Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
17%
Over the last year, the Accounts Receivables growth was -10%. The average annual Accounts Receivables growth rates for STCube Inc have been 55% over the past three years , 10% over the past five years , and 17% over the past ten years .
